Page 72«..1020..71727374..8090..»

Skin cells provide a new weapon against brain tumors – Blasting News

By LizaAVILA

Scientists claim that #Stem Cells obtained from skin provide a new weapon against brain tumors. Jedd Wolchok, a cancer immunotherapy expert at the Memorial Sloan Kettering Cancer Center, says that nanoparticles are thinner than a human hair, and help to fight tumors. Previously, doctors used stem cells to target breast cancer tumors. Latest clinical trials show that the new therapy is useful for patients with brain tumors. According to a study published in the journal "Science Translational Medicine," the treatment shrinks the tumors and extends the survival of victims.

Researcher says that it's time to forget about drugs that spur the immune system to fight tumors. Stem cells will be used on a large scale to treat patients. Every year, pharmaceutical companies develop a number of antibodies and proteins that block the overexpressed molecules, enabling the immune system to target tumors. All these medicines are harmful to the nervous system. In contrast, the stem cells directly target a tumor without damaging the neurons. Jedd Wolchok believes that the current anti-cancer drugs work in only 10% to 40% of patients. There is no use of drugs that target only several cells of a tumor and fail to completely destroy it. Stem cells destroy a tumor within a few minutes. However, the process is very complicated and only experienced neurosurgeons should perform an operation. Once a patient receives radiation therapy to shrink a tumor, his immune system mounts an aggressive response that wipes out both the tumors and metastases throughout the body.

Jedd Wolchok will find out whether it is possible to use nontoxic nanoparticles to sensitize the immune system or not. He requires more time and further research before he publishes his findings. He says that it is not easy to pass the nanoparticles through the tumors as the particles are bigger than macrophages. However, specific blood proteins can be used to coat the nanoparticles, facilitating their uptake. Once these particles reach the brain tumor, they act as tumor killers. Jedd and his team will carry out an experiment on mice with breast cancer. Wolchok builds his study on an earlier discovery that brain stem cells have a weird affinity for cancers. #Beat The Clock

Continued here:
Skin cells provide a new weapon against brain tumors - Blasting News

To Read More: Skin cells provide a new weapon against brain tumors – Blasting News
categoriaSkin Stem Cells commentoComments Off on Skin cells provide a new weapon against brain tumors – Blasting News | dataMarch 24th, 2017
Read All

SNS FiRe Conference Names ElpisEremo a 2017 FiReStarter Company – Yahoo Finance

By LizaAVILA

SEATTLE, WA--(Marketwired - March 23, 2017) - Strategic News Service (SNS) has selected lpisremo as a 2017 FiReStarter company to be featured at the 15th annual Future in Review (FiRe) Conference. FiRe 2017 will take place October 10-13 at the Stein Eriksen Lodge Deer Valley in Park City, Utah.

Described by The Economist as "the best technology conference in the world," FiRe features global speakers and participants in technology and the global economy, including Elon Musk, Craig Venter, Michael Dell, Vint Cerf, Leroy Hood, Elena Polyakova, Mark Hurd, Paul Jacobs, Cory Doctorow, Kamran Elahian, Ken Goldman, Dharmendra Modha, and many others. FiReStarters are selected based on the strength of their potential to bring positive change to the world, and are showcased at the FiRe conference in panels throughout the event and with ongoing relationships introduced and supported by SNS.

lpisremo is a disruptive precision bioengineering regenerative-medicine company whose platform technology harnesses and instructs the body's own tissue-resident cells, to produce nearly any therapeutic and regenerative protein, in place, with on/off precision, without the need to inject small-molecule drugs, mRNA, stem cells, or chemicals.

lpisremo's bleeding-edge platform enables the precision modulation of cell signaling pathways to elicit specific gene and protein expression of tissue-restricted transcription factors that are the fundamental biological mechanisms contributing to cardiogenesis, chondrogenesis, neurogenesis, vasculogenesis, skeletal myogenesis, osteogenesis, hepatogenesis, and organogenesis, which are the key mechanisms to regenerating and restoring tissue and organ function to its optimum healthy state. lpisremo's precision platform can target the key mechanisms that cause biological aging to elicit adult skin stem cells self-renewal, boost their lifespan, replenish, and elicit prevention and reversion of cellular aging ("reversing the aging process"), with the goal of making aging a reversible phenomenon.

"lpisremo's team is honored to be recognized as a 2017 FiReStarter company. We are extremely excited to share the next-generation regenerative technology at such a highly regarded technology conference, and we look forward to showing how we could revolutionize the way we treat devastating degenerative and debilitating diseases for which no cures or treatments are available today, including aging," said James Ryan, CEO of lpisremo Inc.

"We have invested years into looking at, and in some cases helping to launch, new medical discoveries, technologies, and procedures, from Personalized Medicine to Precision Medicine and including our Nutritional Microanalysis and UnDx (Undiagnosed) initiatives. lpisremo fits perfectly into this universe of brilliant and radically creative new approaches to medicine, and we are delighted to announce its selection as a FiReStarter company this year. We look forward to helping the team share their passion and research and to partnering with them in the future in making the world a better -- and healthier -- place," said Mark Anderson, Founding Chair and CEO of Future in Review and the Strategic News Service.

Future in Review is a gathering of world-class thought leaders, convened each year with the goal of providing the most accurate look forward in technology. FiRe is a world leader in exploring how technology drives the world economy and in using technology to solve major social challenges. These goals have been consistently achieved through FiRe's collaboration across technology-driven industries and through active support from the global FiRe community.

To register for FiRe 2017, go to http://www.futureinreview.com.

Strategic News Service was founded by Mark Anderson in 1995 as the first subscription-based online news service. Since its inception, SNS has proven the most accurate predictive report covering technology and the global economy. Its subscribers include top managers at technology and finance companies across the globe, including Oracle, Microsoft, HP, Dell, Cisco, Intel, Google, British Telecom, SpaceX, Amazon, Telstra, and others.

SNS has been operating the annual FiRe conference since 2003. FiRe exposes world experts and participants to new ideas, and conversations about them, producing an accurate portrait of the future; and focuses on creating technology solutions to current local and global problems. FiRe 2017 will take place October 10-13, 2017, at the Stein Eriksen Lodge Deer Valley in Park City, Utah. For more information and to register, go to http://www.futureinreview.com.

Future in Review is a Strategic News Service conference. Future in Review and Strategic News Service (SNS) are registered international trademarks. The "SNS Global Report on Technology and the Economy" is the most accurate publicly ranked predictive newsletter in computing and communications.

Websites: http://www.stratnews.com, http://www.futureinreview.com, https://www.elpiseremo.com/

Follow this link:
SNS FiRe Conference Names ElpisEremo a 2017 FiReStarter Company - Yahoo Finance

To Read More: SNS FiRe Conference Names ElpisEremo a 2017 FiReStarter Company – Yahoo Finance
categoriaSkin Stem Cells commentoComments Off on SNS FiRe Conference Names ElpisEremo a 2017 FiReStarter Company – Yahoo Finance | dataMarch 23rd, 2017
Read All

Sun Exposure Is No Joke. You Need to Get Your Skin Checked ASAP – Reader’s Digest

By daniellenierenberg

Elena-Rudakova/Shutterstock

Twice a year, I strip down to my underwear, don a paper gown and subject myself to a full-body examination at the dermatologists office. These are done twice as often as most other patientsand for good reason. Not only am I freckly and fair-skinned, Ive had an unhealthy relationship with the sun, which makes me more susceptible to skin cancer.

During my teens and 20s, when I was a lifeguard and camp counselor, I spent the majority of my summers outdoors. Like my peers, Id wanted to achieve the perfect tan. Id worn sunscreen, but it was SPF 4barely any protection, compared with what doctors recommend today.

Now, Im paying the price. This past decade, Ive had a handful of suspicious-looking moles removed. Recently, my dermatologist sent me to a medical photographer for a full-body photo session to document my moles, in case they change.

wavebreakmedia/Shutterstock

My situation isnt unique. Countless people worldwide didnt protect themselves adequately from the suns ultraviolet rays during their youth. Decades ago, doctors didnt preach about sun protection, and researchers didnt realize that the suns ultraviolet rays could cause skin changes that can lead to melanoma, the deadliest form of skin cancer.

The most important reason for the increase in melanomas is thought to be due to increased exposure to ultraviolet radiation from sun and artificial tanning sources, says John J. DiGiovanna, staff clinician in the dermatology branch of the National Cancer Institutes Center for Cancer Research in Bethesda, Maryland.

Melanoma is only the ninth most commonly diagnosed cancer across Europe, but its rates have been rising sharply since the 1980s, six-fold among some groups.

Every year, 100,000 new cases of melanoma are diagnosed in Europe, says John Haanen, head of medical oncology at the Netherlands Cancer Institute in Amsterdam. Caucasians are at greatest risk, especially those with fair skin, red hair and freckles. Risk rises after age 40especially sun worshippers. Many experts refer to the increased prevalence as an epidemic.

I would not call it a melanoma epidemic but a skin cancer epidemic, says Reinhard Dummer, director of the Skin Cancer Centre at University Hospital Zrich. We expect in Switzerland that one out of five persons will develop skin cancers once in their lives.

Cultural changes over several decades are likely to blame. Bathing suits have gotten skimpier, and seaside vacations have become more common, exposing pale office workers to intense sunlight for short periods.

In Europe, low-cost air travel has increased the ability for people to travel to sunny, warmer climates for a week here and there, says Alex Menzies, medical oncologist at Melanoma Institute Australia, the country with the highest melanoma rates in the world. Intermittent exposure to the sun with burning is a major risk for melanoma.

Even if youve endured decades worth of sun exposure, there is hope.

The earlier you notice melanoma, the greater your chances are of being cured. Surgery is the primary treatment. If you picked up an early-changing mole, you could have a virtually normal life expectancy, says Girish Patel, lead investigator for the Skin Cancer Stem Cell Research Program at Cardiff University.

Content continues below ad

Regular skin checks and meaningful lifestyle changes to limit further damage from the sun help improve the odds. Since Imogen Cheese, 37, of Gloucestershire, England, was diagnosed with stage II melanoma in 2013, shes screened by her medical team every three months. I cover up to avoid the midday sun, says Imogen. I wear high factor SPF, I am active and eat a healthy balanced diet. So far, her cancer has not progressed.

Researchers have made great strides in the treatment of advanced melanoma. One option: Targeted therapy, which can be given to stage IV patients with specific genetic mutations.

Melanoma researchers in Australia have been involved with targeted therapy research since the beginning, about seven years ago. We do testing on their tumors to look if there are any mutations in certain genes in the tumor, says Menzies. We have targeted therapy that can attack the BRAF mutation, which is found in about 50 percent of tumors from patients. If we give tablets for BRAF-mutant melanoma, almost every patient will have shrinkage of the tumor. On average, it will keep things under control for one year, and the one-year survival rate has improved to 70 percent, from 30 percent five years ago.

Five years after John Ambrose, 67, of New South Wales, Australia, had a grade IV skin melanoma removed he began coughing up blood. His disease had spread to both lungs and his prognosis was poor. He joined a targeted therapy clinical trial in 2013, and within three months, his tumors shrank by 70 percent. After 18 months, he had clear scans. Today, John travels, plays golf and spends time with his grandchildren.

My situation has not stopped me living a normal life, he says.

Texas native Jesse Thomas, 57, also benefited from targeted therapy after being diagnosed with stage IV melanoma in 2013, with tumors on his neck, liver and spine. Genomic testing revealed Jesse had an uncommon V600K BRAF mutation, and his oncologist was able to pinpoint a targeted therapy for him.

They expected the cancer to stop growing, but it actually shrank, Jesse says. Theres no way to cure it, but I am controllable.

Targeted therapy is only for stage IV patients, but researchers are studying its effects on stage III patients. We should know within a couple of years whether these treatments are beneficial, says John Haanen.

Researchers have been able to stimulate the T-cells in some melanoma patients immune systems to fight cancer, with astounding results.

T-cells kill off viruses and other things, Menzies says, but with cancer, theyre sitting there around the tumor, asleep. They know that the tumor is foreign, but the tumor has turned them off, stopping them from killing it. Immunology drugs turn on the T-cells and they kill the tumor.

Melanoma researchers consider immunology the biggest breakthrough in decades.

This is our penicillin moment in oncology, Menzies says. Melanoma can be turned into a chronic disease, and many people will not die from it in the near future if we continue to go the way were going.

Content continues below ad

Immunotherapy doesnt work for everyone, but it can be quite effective. Cardiff Universitys Patel says, In the 45 or so percent of people who respond, they can respond for very long periods of time.

In 2013, Cardiff resident Vicky Brown, 62, was shocked to learn that a lump in her breast was actually melanoma, not breast cancer. Shed had early-stage melanoma in 2006, which returned in her breast and lungs.

Through a clinical trial, Brown received intravenous doses of two immunotherapy drugs. Within weeks, her tumors shrank. She discontinued the drugs due to side effects, but it kept the melanoma in check for a year. In 2015, after new lung tumors appeared, she received more immunology treatments. The drugs again shrank her tumors.

I am hoping this couple of doses will give me more time again, Vicky says. My grandson is now nine months old. I want to be able to make memories for him, as well as my four-year-old granddaughter.

Researchers are working to get more patients to have a positive response to the treatment. The notion is that clearly, if we can do it in a few, we should be able to do it in the majority, says Patel.

For years, researchers tried creating a melanoma vaccine, to no avail. Now, researchers are combining the success of immunotherapy with the concept of vaccines, leading to personalized melanoma treatments.

As we better understand how the immune system recognizes the melanoma cells, we are developing so-called personalized vaccines, Haanen says. We are starting now in metastatic patients and if this concept works well move to earlier stages.

Hein Jambroers, 50, of Roermond, Netherlands, has benefited from a personalized treatment called adoptive cell therapy (ACT). He was diagnosed with stage II melanoma in 2009, but a year later, he had stage IV disease, with tumors on his right leg and liver, and was told that he had less than six months to live.

After getting some short-term benefit from targeted therapy, Hein was referred to an ACT clinical trial in 2011. Doctors at the Netherlands Cancer Institute harvested some of his white blood cells, then monitored them in a laboratory to identify the healthiest T-cells to fight melanoma. They were replicated in large numbers. Hein received chemotherapy to kill his existing T-cells, then got an infusion of the laboratory-created T-cells, which basically gave him a new immune system that shrank his tumors within three months.

Hes what doctors call a complete responder. Hes had clean scans ever since; no trace of melanoma.

Complete responders have an excellent prognosis, says Haanen, who treated Hein. Cure is always difficult to say, but very long-term remissions which could be cureare seen in the majority of complete responders and in some partial responders.

Hein, who expected to die, is cautiously optimistic. Im very positive about my future, but Im always on a state of alert, he says. I sit in the shade. I cream up with sunscreen. I even do it for my child and my wife. I dont want to tempt the fates.

Content continues below ad

Soon, doctors may defeat cancer by attacking stem cells.

Skin stem cells make thousands of healthy skin cells. Melanoma stem cells work similarly, except they make thousands of malignant melanoma cells. Researchers are targeting melanoma stem cells to stop tumors from spreading.

Its like killing off the queen bee, Patel says. The whole hive then dies away, because youve gotten to the cell thats giving rise to everything.

This is vastly different from chemotherapy, which aims to kill as much cancer as possible. Stem cells make up only one to three per cent of some skin cancers.

If you got rid of the cancer stem cell population, the whole tumor could not proliferate, Patel says. If you take the bulk of a tumor and regrow it in a mouse without stem cells, it cant form. But if you take a small part of the cancer stem cell population, it grows back fully.

Researchers have begun clinical trials, and treatments could be available in a decade.

Despite sun damage that I endured during my youth, Im optimistic that Im doing everything that I can to stay ahead of any problems that may crop up. Ive got photos of all of my moles and freckles now, which I use for monthly self-exams. Ill bring them to my dermatologist for my next full-body examination. Ive also been raising my children with 21st century values for sun exposureplenty of high-SPF sunscreen, hats and time in the shadeso hopefully the next generation wont have the melanoma worries that my generation does.

If youve been diagnosed with advanced melanoma, heres what patient advocates recommend:

See a specialist

Seek a facility where doctors specialize in melanoma. Our recommendation for patients is to get into a melanoma center of excellence, says Bettina Ryll, founder of Melanoma Patient Network Europe in Uppsala, Sweden. The new immunotherapies have very different side effects from anything weve ever had before, so you dont want to have a physician who has never seen this.

Consider a clinical trial

Availability of immunotherapy and targeted therapy varies in Europe. Cost is a factor in many countries. Many patients enter clinical trials to receive these drugs. A promising clinical trial may be farther from home than youd prefer, but the extra drive could be worth it. Rory Bernard, 47, of Clermont-Ferrand, France, travels four hours to Paris for targeted therapy treatments, which have shrunk his tumors and extended his life. The dermatologist said, If you stay here, youre dead in six months, says Rorys wife, Gilly Spurrier-Bernard, founder of Melanoma France. My aim is to inform patients that if they want to get the best treatment, they may need to move around. Translation translation transl translation translation transl translation translation.

Read more here:
Sun Exposure Is No Joke. You Need to Get Your Skin Checked ASAP - Reader's Digest

To Read More: Sun Exposure Is No Joke. You Need to Get Your Skin Checked ASAP – Reader’s Digest
categoriaSkin Stem Cells commentoComments Off on Sun Exposure Is No Joke. You Need to Get Your Skin Checked ASAP – Reader’s Digest | dataMarch 22nd, 2017
Read All

Disruptive innovations – The News International

By NEVAGiles23

Neuroscientists at the Wisconsin-based Wicab Inc have developed a device called BrainPort that helps blind people see with their tongues. According to the late co-founder of the company, neuroscientist Paul Bach-y-Rita, we see with our brains and not with our eyes, so it should be possible to develop devices that allow the blind to see.

BrainPort involves collecting visual data using a small digital camera that the blind person wears on a pair of sunglasses. The digital optical signals are then converted by a central processing unit (CPU) about the size of a cell phone that the blind person carries in his/her pocket into electrical signals, simulating and replacing the function of the retina. The CPU then sends the signals to sensors on the surface of a lollipop-like device that the blind person carries in the mouth. The nerves on the tongue receive these signals and transmit them to the brain, thereby creating the images of the object being viewed. With a little learning, the user can distinguish between a knife and a fork on the dining table and read letters and numbers and decipher them on the buttons in an elevator.

The device originally announced in 2009 has been tested extensively at the University of Pittsburgh Medical Centres UPMC Eye Centre and is now commercially available. In a subsequent development, the images can be transferred to the brain by an arm band through the nervous system in the arms. This avoids the use of lollipop devices.

Another way to restore vision for the blind has been developed by Prof. Michael Beauchamp at the University of Texas. He is exploring the possibility of electrically stimulating the visual cortex of the brain by means of electrical implants. He also believes that we see not with our eyes but with our brains and if electrical images generated from the visual objects can be transferred to the correct region of the brain, vision can be restored. About 10 percent of the blind people experience vivid hallucinations. This is attributed to the hyperactivity of the visual cortex of the brain and the images produced can be seen in exquisite detail. It is envisaged that a webcam fitted on the glasses of the blind person could be connected to an implant in the brain to restore vision.

The ability to record brain activity while seeing an image, and then play it back to reconstruct that image has been a matter of pure science fiction until now. Scientists working at the University of California, Berkeley, have succeeded in reconstructing visual images after recording the brain activity of people watching movie trailers. The scientists were able to see what peoples brains were seeing. They used a functional Magnetic Resonance Imaging (fMRI) scanner to record the flow of blood in certain parts of the brain. Using powerful computing techniques, it was possible to correlate the visual images with corresponding brain activities. This allowed the images to be reconstructed. The researchers hope to eventually read the thoughts of patients in a coma or those suffering from a paralysis after a stroke. They can even apply these techniques on spies who are trying to hide information. Researchers have now also succeeded in reconstructing words by detecting peoples corresponding brain activity.

Another area of intense research activity is that of regenerative medicine that involves the growth of human cells and tissues. Indeed stem cell therapy is heralding the advent of a revolution in medicine to repair damaged kidney and heart cells and to treat diabetes and other diseases. Stem cells can be differentiated into different types of specialised cells (heart, kidney, pancreas etc). Adult stem cell therapies have been used for a long time to treat leukaemia and other cancers by bone marrow transplants.

Now a special bandage, seeded with stem cells, has been developed by scientists at the Bristol University in the UK to repair cartilage tears that are otherwise difficult to heal. The bone marrow is extracted from the hip of the patient with a needle. Stem cells are obtained from it and multiplied separately before being embedded into a special membrane/bandage which is inserted into the torn cartilage. The stem cells present on the membrane are expected to help the healing process. The procedure can help repair meniscus tears that are particularly common in athletes.

Ink jet printers are commonly used for printing documents. An astounding breakthrough has been made by doctors at the Wake Forest Institute of Regenerative Medicine in the US where a device that resembles an ink jet printer can be used to spray new skin cells on to burn wounds. This method results in rapid healing and can eventually replace the need for having skin grafts. The device resembles a colour ink jet printer and comprises a tank that contains skin cells, stem cells and nutrients. These are sprayed by a computer controlled nozzle directly on to the burnt area. In animal experiments, the wounds in mice were fully healed within two weeks using this technique compared to the five-week period that skin graft procedures took. The ink jet printer method also showed less scarring and better hair regeneration. The technology is being employed by the US army to print-shut bullet wounds and blast damage.

Magicians have been practising the art of making objects disappear for centuries. Now, science can take on that role. In 2006, Prof. John Pendry and his colleagues proposed the design of a cloak that could steer light around an object, making it invisible. Soon thereafter Dr David Smith at Duke University made a cloaking device that used certain metamaterials that had unusual electromagnetic properties. The invisible threads of these metamaterials are made of components smaller than the wavelength of light. This allows them to bend light waves and impart optical properties that are not present in normal substances. Computer models indicate that such threads should not be thicker than a micrometre. When these carpet cloaks are placed over an object, the object becomes invisible.

The technology has applications in defence: it may allow soldiers, weapons, warships and planes to appear invisible. Harry Potters cloak of invisibility is fast becoming a reality. Invisible armies, ships, planes and submarines cloaked by metamaterials seem like a possibility in the near future.

Countries investing in these cutting edge researches are making billions of dollars through such entrepreneurial ventures. If Pakistan is to prosper, we must give the highest national priority to education, science, technology, innovation and entrepreneurship. This requires a visionary government that understands the critical role of a knowledge-based economy in the rapidly changing world of today.

The writer is chairman of UN ESCAP Committee on Science Technology & Innovation and former chairman of the HEC.

Email: [emailprotected]

Read this article:
Disruptive innovations - The News International

To Read More: Disruptive innovations – The News International
categoriaSkin Stem Cells commentoComments Off on Disruptive innovations – The News International | dataMarch 22nd, 2017
Read All

Borrowing from nature: UW-Madison scientists use plants to grow stem cells – Madison.com

By Sykes24Tracey

To grow clusters of human stem cells that mimic organs in the lab and might be used someday in tissue implants, Bill Murphy, a UW-Madison professor of biomedical engineering, creates tiny scaffolds made of plastic or rubber.

The three-dimensional scaffolds must support the cells and feed them, help them organize and allow them to communicate.

One spring day in 2014, Murphy looked out his office window near UW Hospital, onto the universitys Lakeshore Nature Preserve, and saw a structure that does those very things naturally: plants specifically, cellulose, the main component of the cell walls of green plants.

Now, Murphy and Gianluca Fontana, a UW-Madison post-doctoral fellow with help from Olbrich Botanical Gardens have grown skin, brain, bone marrow and blood vessel cells on cellulose from plants such as parsley, spinach, vanilla and bamboo.

Plants could be an alternative to artificial scaffolds for growing stem cells, the researchers reported Monday in the journal Advanced Healthcare Materials.

Rather than having to manufacture these devices using high-tech approaches, we could literally pick them off of a tree, said Murphy, co-director of the UW-Madison Stem Cell and Regenerative Medicine Center.

The strength, porosity and large surface area of plants could prove superior to making scaffolds using current methods, such as 3-D printing and injection molding, Murphy said.

Plants have a huge capacity to grow cell populations, he said. They can deliver fluids very efficiently to their leaves ... At the microscale, theyre very well organized.

In addition, there are many plants to chose from. After Murphys inspirational gaze out the window, he and Fontana tested plants as scaffolds for stem cells using varieties they could easily obtain: parsley, spinach, jewelweed, water horsetail, summer lilac and, from the UW Arboretum, softstem bulrush.

Then Fontana asked John Wirth, Olbrichs conservatory curator, about other species that might work. Wirth invited Fontana to walk through the tropical greenhouse and take samples back to his lab.

I had never had a request like this before; it made me look at plant material in a different way, Wirth said. I think its a fantastic way of using these pieces of living tissue, to grow human tissue.

Olbrich plants that proved useful include vanilla, bamboo, wasabi, elephant ear, zebra plant and various orchids.

To use plants as scaffolds, the scientists strip away all of the cells, leaving husks of cellulose. Since human cells have no affinity for plants, they add peptides as biological fasteners.

Theyre like grappling hooks for the cells to attach to the plant, Murphy said.

To determine if plant scaffolds could really replace those made of plastic or rubber, the researchers hope to test the cellulose models in animal studies this year.

A major goal of tissue engineering is to develop implants that could regenerate tissue in people to repair bone or muscle damage after traumatic injuries, for example.

It is likely the human body wouldnt reject tissue implants formed on plant scaffolds because the plant cells would be removed, Murphy said.

Were crossing kingdoms, he said. But were optimistic that these materials would be well-tolerated.

Originally posted here:
Borrowing from nature: UW-Madison scientists use plants to grow stem cells - Madison.com

To Read More: Borrowing from nature: UW-Madison scientists use plants to grow stem cells – Madison.com
categoriaSkin Stem Cells commentoComments Off on Borrowing from nature: UW-Madison scientists use plants to grow stem cells – Madison.com | dataMarch 22nd, 2017
Read All

Testing the efficacy of new gene therapies more efficiently … – Science Daily

By JoanneRUSSELL25

Testing the efficacy of new gene therapies more efficiently ...
Science Daily
Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and ...

and more »

See original here:
Testing the efficacy of new gene therapies more efficiently ... - Science Daily

To Read More: Testing the efficacy of new gene therapies more efficiently … – Science Daily
categoriaSkin Stem Cells commentoComments Off on Testing the efficacy of new gene therapies more efficiently … – Science Daily | dataMarch 22nd, 2017
Read All

A Groundbreaking Stem Cell Treatment Just Prevented a Woman From Going Blind – Futurism

By raymumme

In Brief

Macular degeneration affects more than 10 million people in the U.S., and is the most common cause of vision loss. It is caused by the deterioration of the middle of the retina, called the macula. The macula focuses central vision and controls our ability to see objects in fine detail, read, recognize colors and faces, and drive a car. Until now, the disease has been considered incurable.

An octogenarian with the condition is now the first person to receivesuccessful treatmentwith induced pluripotent stem (iPS) cells. The progression of the womans macular degenerationwas arrested by new retinal cells made in the lab.Unlike embryonic stem cells, iPS cells can be created from regular adult cells.In this case, the cells used to repair the damaged retina from macular degeneration came from the womansskin.

The team at Kobe, Japans RIKEN Laboratory for Retinal Regeneration, led by Masayo Takahashi, created iPS cells from the patients skin cells. Then, theyencouraged them to form cells to patch the retinal pigment epithelium. These cells help nourish and support the retina, allowing it to capture the light the eye needs to see.

Once the cells were transformed, the team used them to make a slither measuring 1 by 3 millimeters. This was the patch they used to replace the diseased tissue removed from the patients retina. Their aim was to stop the degeneration and save her sight. The results show that the procedure was technically a success: although her vision did not improve, the degeneration stopped.

A possible concern about this treatment, however, is that creating new tissues from stem cells could cause genetic mutations, which might in turnlead to cancer. While more research in this area and its possible applications is needed, in the case of the patient at RIKEN, therehave been no signs of cancer or any other complications.

Read more from the original source:
A Groundbreaking Stem Cell Treatment Just Prevented a Woman From Going Blind - Futurism

To Read More: A Groundbreaking Stem Cell Treatment Just Prevented a Woman From Going Blind – Futurism
categoriaSkin Stem Cells commentoComments Off on A Groundbreaking Stem Cell Treatment Just Prevented a Woman From Going Blind – Futurism | dataMarch 20th, 2017
Read All

Stem cells seem speedier in space – Phys.Org

By JoanneRUSSELL25

March 20, 2017 by Melissa Gaskill Cultured stem cells. Credit: BioServe Inc., University of Colorado

Growing significant numbers of human stem cells in a short time could lead to new treatments for stroke and other diseases. Scientists are sending stem cells to the International Space Station to test whether these cells proliferate faster in microgravity without suffering any side effects.

Therapeutic uses require hundreds of millions of stem cells and currently no efficient way exists to produce such quantities. Previous research suggests that microgravity could help, and the space station is home to the nation's only national lab in microgravity.

Some types of stem cells grow faster in simulated microgravity, according to Abba Zubair, a researcher at the Mayo Clinic in Jacksonville, Florida. Zubair is principal investigator for the Microgravity Expanded Stem Cells investigation, which is cultivating human stem cells aboard the space station for use in clinical trials back on Earth. He holds a doctor of medicine degree in transfusion medicine and cell therapy and a doctorate of philosophy in tumor immunology.

Human stem cells are cells that have not yet specialized in function and can divide into a spectrum of cell types, rejuvenating and repairing tissue throughout a person's lifetime. Stem cells in every organ of the body, including skin and bones, maintain those organs and repair tissue by dividing and differentiating into specialized cells.

Harvesting a person's stem cells and growing enough of them for use in therapies has proven difficult, though. Researchers have successfully grown mesenchymal stem cells, found in bone marrow, but growing sufficient quantities takes weeks. That could be too late for treatment of some conditions.

"Stem cells are inherently designed to remain at a constant number," Zubair explains. "We need to grow them faster, but without changing their characteristics."

The first phase of the investigation, he adds, is answering the question: "Do stem cells grow faster in space and can we grow them in such a manner that they are safe to use in patients?"

Investigators will examine the space-grown cells in an effort to understand the mechanism behind microgravity's effects on them. The long-term goal is to learn how to mimic those effects and develop a safe and reliable way to produce stem cells in the quantities needed.

The second phase will involve testing clinical application of the cells in patients. Zubair has been studying treatment of stroke patients with lab-grown stem cells and plans to compare those results with use of the space-grown stem cells.

"What is unique about this investigation is that we are not only looking at the biology of the cells and how they grow, but focusing on application, how we can use them to treat patients," he says.

The investigation expands existing knowledge of how microgravity affects stem cell growth and differentiation as well as advances future studies on how to produce large numbers of stem cells for treating stroke and other conditions.

The faster that happens, the better for those who could benefit from stem cell therapies.

Explore further: Study shows adipose stem cells may be the cell of choice for therapeutic applications

An international team of researchers, funded by Morris Animal Foundation, has shown that adipose (fat) stem cells might be the preferred stem cell type for use in canine therapeutic applications, including orthopedic diseases ...

Abba Zubair, M.D., Ph.D, believes that cells grown in the International Space Station (ISS) could help patients recover from a stroke, and that it may even be possible to generate human tissues and organs in space. He just ...

Consider it one physician's giant leap for mankind. Today, the latest rocket launch from NASA's Kennedy Space Center in Cape Canaveral, Florida, included a payload of several samples of donated adult stem cells from a research ...

NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in ...

A study performed on the NASA Space Shuttle Discovery showed that exposure of mouse embryonic stem cells (mESCs) to microgravity inhibited their ability to differentiate and generate most cell lineages, needed for the development ...

Stem cells hold great promise for transforming medical care related to a diverse range of conditions, but the cells often lose some of their therapeutic potential when scientists try to grow and expand them in the laboratory. ...

As children, we learned about our solar system's planets by certain characteristicsJupiter is the largest, Saturn has rings, Mercury is closest to the sun. Mars is red, but it's possible that one of our closest neighbors ...

(Phys.org)Astronomers have inspected a mysterious isolated star cluster complex designated SH2 in the galaxy NGC 1316 (also known as Fornax A). The results of their study, which were published Mar. 1 in a paper on arXiv.org, ...

Growing significant numbers of human stem cells in a short time could lead to new treatments for stroke and other diseases. Scientists are sending stem cells to the International Space Station to test whether these cells ...

Astronomers studying Mars first noted the presence of yellow clouds on its surface in the 1870's. Today these windblown dust storms on Mars are well known, and can span local, regional or even global in scale. Storms can ...

A SpaceX reusable cargo ship splashed down in the Pacific Ocean safely on Sunday, ending a mission to supply astronauts on the International Space Station, the company said.

Johns Hopkins University scientist Kirby Runyon wants to make one thing clear: Regardless of what one prestigious scientific organization says to the contrary, Pluto is a planet. So is Europa, commonly known as a moon of ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Link:
Stem cells seem speedier in space - Phys.Org

To Read More: Stem cells seem speedier in space – Phys.Org
categoriaSkin Stem Cells commentoComments Off on Stem cells seem speedier in space – Phys.Org | dataMarch 20th, 2017
Read All

Borrowing from nature: UW-Madison scientists use plants to grow … – La Crosse Tribune

By NEVAGiles23

To grow clusters of human stem cells that mimic organs in the lab and might be used someday in tissue implants, Bill Murphy, a UW-Madison professor of biomedical engineering, creates tiny scaffolds made of plastic or rubber.

The three-dimensional scaffolds must support the cells and feed them, help them organize and allow them to communicate.

One spring day in 2014, Murphy looked out his office window near UW Hospital, onto the universitys Lakeshore Nature Preserve, and saw a structure that does those very things naturally: plants specifically, cellulose, the main component of the cell walls of green plants.

Now, Murphy and Gianluca Fontana, a UW-Madison post-doctoral fellow with help from Olbrich Botanical Gardens have grown skin, brain, bone marrow and blood vessel cells on cellulose from plants such as parsley, spinach, vanilla and bamboo.

Plants could be an alternative to artificial scaffolds for growing stem cells, the researchers reported Monday in the journal Advanced Healthcare Materials.

Rather than having to manufacture these devices using high-tech approaches, we could literally pick them off of a tree, said Murphy, co-director of the UW-Madison Stem Cell and Regenerative Medicine Center.

The strength, porosity and large surface area of plants could prove superior to making scaffolds using current methods, such as 3-D printing and injection molding, Murphy said.

Plants have a huge capacity to grow cell populations, he said. They can deliver fluids very efficiently to their leaves ... At the microscale, theyre very well organized.

In addition, there are many plants to chose from. After Murphys inspirational gaze out the window, he and Fontana tested plants as scaffolds for stem cells using varieties they could easily obtain: parsley, spinach, jewelweed, water horsetail, summer lilac and, from the UW Arboretum, softstem bulrush.

Then Fontana asked John Wirth, Olbrich's conservatory curator, about other species that might work. Wirth invited Fontana to walk through the tropical greenhouse and take samples back to his lab.

I had never had a request like this before; it made me look at plant material in a different way, Wirth said. I think its a fantastic way of using these pieces of living tissue, to grow human tissue.

Olbrich plants that proved useful include vanilla, bamboo, wasabi, elephant ear, zebra plant and various orchids.

To use plants as scaffolds, the scientists strip away all of the cells, leaving husks of cellulose. Since human cells have no affinity for plants, they add peptides as biological fasteners.

Theyre like grappling hooks for the cells to attach to the plant, Murphy said.

To determine if plant scaffolds could really replace those made of plastic or rubber, the researchers hope to test the cellulose models in animal studies this year.

A major goal of tissue engineering is to develop implants that could regenerate tissue in people to repair bone or muscle damage after traumatic injuries, for example.

It is likely the human body wouldn't reject tissue implants formed on plant scaffolds because the plant cells would be removed, Murphy said.

Were crossing kingdoms, he said. But were optimistic that these materials would be well-tolerated.

Read more:
Borrowing from nature: UW-Madison scientists use plants to grow ... - La Crosse Tribune

To Read More: Borrowing from nature: UW-Madison scientists use plants to grow … – La Crosse Tribune
categoriaSkin Stem Cells commentoComments Off on Borrowing from nature: UW-Madison scientists use plants to grow … – La Crosse Tribune | dataMarch 20th, 2017
Read All

Science in Focus: Creating Neurons from Skin Cells to Understand … – UCSF News Services

By LizaAVILA

Studying brain disorders is complicated for many reasons, not the least being the ethics of obtaining living neurons. To overcome that obstacle, UC San Francisco postdoc Aditi Deshpande, PhD, is starting with skin cells.

Thanks to developments in stem cell technology, new information about the human brain is now being gleaned from a simple cheek swab or skin sample. This technology is key to the kind of progress Despande and researchers like her are making. It allows them to work with cells otherwise unobtainable living brain cells that have the same genetics as the patients.

Deshpande begins with skin cells obtained from the Simons Foundation from volunteers whose DNA contains a specific deletion or duplication of one chromosome. She cultures these cells and then turns them into induced pluripotent stem cells cells that have been coaxed back to their embryonic state and are able to become any other type of cell. From there, she reprograms them to become a specific type of neuron thats involved in attention and information processing.

The deletion or duplication Deshpande is looking for stems from a 2008 finding by Lauren Weiss, PhD, an associate professor of neurology in the UCSF Department of Psychiatry and the UCSF Institute for Human Genetics.

Weiss discovered a 29-gene region of DNA on chromosome 16 that is associated with autism, seizures and other brain disorders. Normally, a person has two copies of the region one on each copy of chromosome 16. In some of Deshpandes samples, the region is deleted from one chromosome, leaving one copy. In others, the region is duplicated, resulting in three copies. Subjects with only one copy of the region were more likely to have macrocephaly an enlarged brain than a typical subject, and those with three copies were more likely to have microcephaly a smaller brain.

Whats really interesting, said Deshpande, is that although these subjects seem to have opposite features in terms of brain size, we see a related effect, based on whether they have fewer or more copies of the region.

Some known models of autism show a connection between a neurons growth or appearance and macrocephaly, she explained. We wanted to know if the same thing is happening here.

To compare the effect of the mutation, Deshpande first stains the obtained skin cells so that she can visualize the neurons under a microscope. After staining, Deshpande used cell-counting software to assess several thousands of neurons from deletion and duplication samples and measure them against normal neurons. She found that the neurons missing the DNA region exhibited some differences compared to typical neurons.

Her next step in her research is to discern which of the regions 29 genes are involved in these differences.

The work is meticulous, but Deshpande doesnt mind. I simply love looking at neurons, she said. It really makes you appreciate the complexity of the brain.

View original post here:
Science in Focus: Creating Neurons from Skin Cells to Understand ... - UCSF News Services

To Read More: Science in Focus: Creating Neurons from Skin Cells to Understand … – UCSF News Services
categoriaSkin Stem Cells commentoComments Off on Science in Focus: Creating Neurons from Skin Cells to Understand … – UCSF News Services | dataMarch 19th, 2017
Read All

Study Yields Neural Crest Cells from Adult Skin Cells Without Genetic Modification – Scicasts (press release) (blog)

By Dr. Matthew Watson

Buffalo, NY (Scicasts) A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.

The practical implications could be very significant, from studying genetic diseases in a dish to generating possible regenerative cures from the patient's own cells.

"It's actually quite remarkable that it happens," says Dr. Stelios T. Andreadis, professor and chair of UB's Department of Chemical and Biological Engineering, who recently published a paper on the results in the journal Stem Cells.

The identity of the cells was further confirmed by lineage tracing experiments, where the reprogrammed cells were implanted in chicken embryos and acted just as neural crest cells do.

Stem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign genetic material. The reprogrammed neural crest cells can become smooth muscle cells, melanocytes, Schwann cells or neurons.

"In medical applications this has tremendous potential because you can always get a skin biopsy," Andreadis says. "We can grow the cells to large numbers and reprogram them, without genetic modification. So, autologous cells derived from the patient can be used to treat devastating neurogenic diseases that are currently hampered by the lack of easily accessible cell sources."

The process can also be used to model disease. Skin cells from a person with a genetic disease of the nervous system can be reprogrammed into neural crest cells. These cells will have the disease-causing mutation in their chromosomes, but the genes that cause the mutation are not expressed in the skin. The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to study the disease in a dish. This is similar to induced pluripotent stem cells, but without genetic modification or reprogramming to the pluripotent state.

The discovery was a gradual process, Andreadis says, as successive experiments kept leading to something new. "It was one step at a time. It was a very challenging task that took almost five years and involved a wide range of expertise and collaborators to bring it to fruition," Andreadis says. Collaborators include Dr. Gabriella Popescu, professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB; Dr. Song Liu, vice chair of biostatistics and bioinformatics at Roswell Park Cancer Institute and a research associate professor in biostatistics UB's School of Public Health and Health Professions; and Dr. Marianne Bronner, professor of biology and biological engineering, California Institute of Technology.

Andreadis credits the persistence of his then-PhD student, Vivek K. Bajpai, for sticking with it.

"He is an excellent and persistent student," Andreadis says. "Most students would have given up." Andreadis also credits a seed grant from UB's office of the Vice President for Research and Economic Development's IMPACT program that enabled part of the work.

The work recently received a $1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinson's-like symptoms in a mouse model of hypomyelinating disease.

"This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases. We are excited about this discovery and its potential impact and are grateful to NIH for the opportunity to pursue it further," Andreadis said.

Article adapted from a University at Buffalo news release.

Publication: Reprogramming Postnatal Human Epidermal Keratinocytes Toward Functional Neural Crest Fates. Stelios T. Andreadis et al. Stem Cells (2017): Click here to view.

Link:
Study Yields Neural Crest Cells from Adult Skin Cells Without Genetic Modification - Scicasts (press release) (blog)

To Read More: Study Yields Neural Crest Cells from Adult Skin Cells Without Genetic Modification – Scicasts (press release) (blog)
categoriaSkin Stem Cells commentoComments Off on Study Yields Neural Crest Cells from Adult Skin Cells Without Genetic Modification – Scicasts (press release) (blog) | dataMarch 18th, 2017
Read All

How Stem Cells Could Help Scientists Study Eating Disorders – KPBS

By Sykes24Tracey

Aired 3/16/17 on KPBS News.

A research team led by UC San Diego scientists have created a lab-grown model of the anorexic brain using stem cells derived from patients with the eating disorder.

Researchers led by San Diego scientists have created a lab-grown model of the anorexic brain using stem cells derived from patients with the eating disorder. They say the results provide further evidence for understanding anorexia as largely genetically based, rather than primarily as a socially conditioned behavior.

"There's a stigma regarding eating disorders that it's something social," said UC San Diego researcher Alysson Muotri. "But in fact, our results point to a strong genetic factor. And moreover, it suggests there's a specific pathway in the brain that is altered."

For the study published Tuesday in the journal Translational Psychiatry, Muotri and his colleagues took skin cells from seven anorexia patients and then converted them into stem cells in the lab. They then coaxed those stem cells into brain cells, providing scientists with a new model for studying the eating disorder.

Muotri, who has developed similar models for other diseases, said the "disease-in-a-dish" approach is great for studying neurological disorders. Scientists wanting to study these diseases "can't just open the skull and look through the brain cells," he said.

The researchers compared anorexic brain models with other models built from cells taken from four non-anorexic people, most of them relatives of the anorexic patients. The researchers found a difference in the TACR1 gene between the two groups.

Muotri admits the number of patients studied was small, but says these results support "the idea that anorexia has a fundamental biological basis on the perception of fat in the body."

Anorexia experts not involved in the study told KPBS this is another step toward understanding the underlying biology of a misunderstood and often deadly disease.

Walter Kaye, director of the UCSD Eating Disorder Research and Treatment Program, said in an email to KPBS that the findings establish an interesting link between anorexia and a genetic pathway known to play a role in anxiety and fat metabolism.

"This may be a very important clue to understanding puzzling symptoms in anorexia nervosa, such as why food is often associated with anxiety, and why patients see themselves as fat and tend to avoid fat-containing foods," Kaye wrote.

Christina Wierenga, co-director of the eating disorder research program at UCSD, wrote in an email to KPBS, "Although the sample size is small, this elegant study is the first of its kind to examine gene expression in neurons derived from individuals with anorexia and sheds new light on possible causes of anorexia. Of course, replication in larger samples is needed."

To view PDF documents, Download Acrobat Reader.

Continue reading here:
How Stem Cells Could Help Scientists Study Eating Disorders - KPBS

To Read More: How Stem Cells Could Help Scientists Study Eating Disorders – KPBS
categoriaSkin Stem Cells commentoComments Off on How Stem Cells Could Help Scientists Study Eating Disorders – KPBS | dataMarch 18th, 2017
Read All

From Skin to Brain: Stem Cells Without Genetic Modification

By NEVAGiles23

For Release: March 15, 2017 Contact: Grove Potter, mpotter3@buffalo.edu University at Buffalo 716-645-2130 From skin to brain: Stem cells without genetic modification

UB study yields neural crest cells from adult skin cells, and could lead to new treatments for Parkinsons and other brain illnesses

BUFFALO, N.Y. A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.

The applications could be very significant, from studying genetic diseases in a dish to generating possible regenerative cures from the patients own cells.

Its actually quite remarkable that it happens, says Stelios T. Andreadis, PhD, professor and chair of UBs Department of Chemical and Biological Engineering, who recently published a paper on the results in the journal Stem Cells.

The identity of the cells was further confirmed by lineage tracing experiments, where the reprogrammed cells were implanted in chicken embryos and acted just as neural crest cells do.

Stem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign genetic material. The reprogrammed neural crest cells can become smooth muscle cells, melanocytes, Schwann cells or neurons.

In medical applications this has tremendous potential because you can always get a skin biopsy, Andreadis says. We can grow the cells to large numbers and reprogram them, without genetic modification. So, autologous cells derived from the patient can be used to treat devastating neurogenic diseases that are currently hampered by the lack of easily accessible cell sources.

The process can also be used to model disease. Skin cells from a person with a genetic disease of the nervous system can be reprogrammed into neural crest cells. These cells will have the disease-causing mutation in their chromosomes, but the genes that cause the mutation are not expressed in the skin. The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to study the disease in a dish. This is similar to induced pluripotent stem cells, but without genetic modification or reprograming to the pluripotent state.

The discovery was a gradual process, Andreadis says, as successive experiments kept leading to something new. It was one step at a time. It was a very challenging task that took almost five years and involved a wide range of expertise and collaborators to bring it to fruition, Andreadis says. Collaborators include Gabriella Popescu, PhD, professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB; Song Liu, PhD, vice chair of biostatistics and bioinformatics at Roswell Park Cancer Institute and a research associate professor in biostatistics UBs School of Public Health and Health Professions; and Marianne Bronner, PhD, professor of biology and biological engineering, California Institute of Technology.

Andreadis credits the persistence of his then-PhD student, Vivek K. Bajpai, for sticking with it.

He is an excellent and persistent student, Andreadis says. Most students would have given up. Andreadis also credits a seed grant from UBs office of the Vice President for Research and Economic Developments IMPACT program that enabled part of the work. The work recently received a $1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinsons-like symptoms in a mouse model of hypomyelinating disease. This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases. We are excited about this discovery and its potential impact and are grateful to NIH for the opportunity to pursue it further, Andreadis said.

The research, described in the journal Stem Cells under the title Reprogramming Postnatal Human Epidermal Keratinocytes Toward Functional Neural Crest Fates, was supported by grants from the National Institutes of Health.

SEE ORIGINAL STUDY

Read more:
From Skin to Brain: Stem Cells Without Genetic Modification

To Read More: From Skin to Brain: Stem Cells Without Genetic Modification
categoriaSkin Stem Cells commentoComments Off on From Skin to Brain: Stem Cells Without Genetic Modification | dataMarch 16th, 2017
Read All

From Skin to Brain: Stem Cells Without Genetic Modification – Bioscience Technology

By daniellenierenberg

A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.

The practical implications could be very significant, from studying genetic diseases in a dish to generating possible regenerative cures from the patient's own cells.

"It's actually quite remarkable that it happens," said Stelios T. Andreadis, Ph.D., professor and chair of UB's Department of Chemical and Biological Engineering, who recently published a paper on the results in the journal Stem Cells.

The identity of the cells was further confirmed by lineage tracing experiments, where the reprogrammed cells were implanted in chicken embryos and acted just as neural crest cells do.

Stem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign genetic material. The reprogrammed neural crest cells can become smooth muscle cells, melanocytes, Schwann cells or neurons.

"In medical applications this has tremendous potential because you can always get a skin biopsy," Andreadis said. "We can grow the cells to large numbers and reprogram them, without genetic modification. So, autologous cells derived from the patient can be used to treat devastating neurogenic diseases that are currently hampered by the lack of easily accessible cell sources."

The process can also be used to model disease. Skin cells from a person with a genetic disease of the nervous system can be reprogrammed into neural crest cells. These cells will have the disease-causing mutation in their chromosomes, but the genes that cause the mutation are not expressed in the skin. The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to study the disease in a dish. This is similar to induced pluripotent stem cells, but without genetic modification or reprograming to the pluripotent state.

The discovery was a gradual process, Andreadis said, as successive experiments kept leading to something new. "It was one step at a time. It was a very challenging task that took almost five years and involved a wide range of expertise and collaborators to bring it to fruition," Andreadis said. Collaborators include Gabriella Popescu, Ph.D., professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB; Song Liu, Ph.D., vice chair of biostatistics and bioinformatics at Roswell Park Cancer Institute and a research associate professor in biostatistics UB's School of Public Health and Health Professions; and Marianne Bronner, Ph.D., professor of biology and biological engineering, California Institute of Technology.

Andreadis credits the persistence of his then-Ph.D. student, Vivek K. Bajpai, for sticking with it.

"He is an excellent and persistent student," Andreadis said. "Most students would have given up." Andreadis also credits a seed grant from UB's office of the Vice President for Research and Economic Development's IMPACT program that enabled part of the work.

The work recently received a $1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinson's-like symptoms in a mouse model of hypomyelinating disease.

"This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases. We are excited about this discovery and its potential impact and are grateful to NIH for the opportunity to pursue it further," Andreadis said.

See original here:
From Skin to Brain: Stem Cells Without Genetic Modification - Bioscience Technology

To Read More: From Skin to Brain: Stem Cells Without Genetic Modification – Bioscience Technology
categoriaSkin Stem Cells commentoComments Off on From Skin to Brain: Stem Cells Without Genetic Modification – Bioscience Technology | dataMarch 16th, 2017
Read All

Some genetic variations difficult to evaluate using current stem cell modeling techniques – Science Daily

By NEVAGiles23


NetDugout
Some genetic variations difficult to evaluate using current stem cell modeling techniques
Science Daily
Stem cell-based disease modeling involves taking cells from patients, such as skin cells, and introducing genes that reprogram the cells into human-induced pluripotent stem cells (hiPSCs). These "master cells" are unspecialized, meaning they can be ...
Would You Slather Blood and Breast Milk on Your Face?Racked

all 19 news articles »

Read more here:
Some genetic variations difficult to evaluate using current stem cell modeling techniques - Science Daily

To Read More: Some genetic variations difficult to evaluate using current stem cell modeling techniques – Science Daily
categoriaSkin Stem Cells commentoComments Off on Some genetic variations difficult to evaluate using current stem cell modeling techniques – Science Daily | dataMarch 16th, 2017
Read All

Science in Focus: Creating Neurons from Skin Cells to Understand Autism – UCSF News Services

By NEVAGiles23

Studying brain disorders is complicated for many reasons, not the least being the ethics of obtaining living neurons. To overcome that obstacle, UC San Francisco postdoc Aditi Deshpande, PhD, is starting with skin cells.

Thanks to developments in stem cell technology, new information about the human brain is now being gleaned from a simple cheek swab or skin sample. This technology is key to the kind of progress Despande and researchers like her are making. It allows them to work with cells otherwise unobtainable living brain cells that have the same genetics as the patients.

Deshpande begins with skin cells obtained from the Simons Foundation from volunteers whose DNA contains a specific deletion or duplication of one chromosome. She cultures these cells and then turns them into induced pluripotent stem cells cells that have been coaxed back to their embryonic state and are able to become any other type of cell. From there, she reprograms them to become a specific type of neuron thats involved in attention and information processing.

The deletion or duplication Deshpande is looking for stems from a 2008 finding by Lauren Weiss, PhD, an associate professor of neurology in the UCSF Department of Psychiatry and the UCSF Institute for Human Genetics.

Weiss discovered a 29-gene region of DNA on chromosome 16 that is associated with autism, seizures and other brain disorders. Normally, a person has two copies of the region one on each copy of chromosome 16. In some of Deshpandes samples, the region is deleted from one chromosome, leaving one copy. In others, the region is duplicated, resulting in three copies. Subjects with only one copy of the region were more likely to have macrocephaly an enlarged brain than a typical subject, and those with three copies were more likely to have microcephaly a smaller brain.

Whats really interesting, said Deshpande, is that although these subjects seem to have opposite features in terms of brain size, we see a related effect, based on whether they have fewer or more copies of the region.

Some known models of autism show a connection between a neurons growth or appearance and macrocephaly, she explained. We wanted to know if the same thing is happening here.

To compare the effect of the mutation, Deshpande first stains the obtained skin cells so that she can visualize the neurons under a microscope. After staining, Deshpande used cell-counting software to assess several thousands of neurons from deletion and duplication samples and measure them against normal neurons. She found that the neurons missing the DNA region exhibited some differences compared to typical neurons.

Her next step in her research is to discern which of the regions 29 genes are involved in these differences.

The work is meticulous, but Deshpande doesnt mind. I simply love looking at neurons, she said. It really makes you appreciate the complexity of the brain.

Read the original here:
Science in Focus: Creating Neurons from Skin Cells to Understand Autism - UCSF News Services

To Read More: Science in Focus: Creating Neurons from Skin Cells to Understand Autism – UCSF News Services
categoriaSkin Stem Cells commentoComments Off on Science in Focus: Creating Neurons from Skin Cells to Understand Autism – UCSF News Services | dataMarch 16th, 2017
Read All

Human Embryonic Stem (ES) Cells from Skin Cells …

By raymumme

The first new finding is an obvious onethe mouse experiments worked in human cells. Just because something worked in mice doesn't necessarily mean it will work in people too. So this is a really important finding.

The second important finding has to do with the specific genes each group used. Both groups added four genes to turn a stem cell into an ES cell. But they used a slightly different set of genes.

The Japanese group added OCT3/4, SOX2, KLF4, and c-MYC. The Wisconsin group added OCT4, SOX2, NANOG, and LIN28. This matters because of a side effect seen in the previous mouse study.

The mouse study went farther than the human study in that the researchers added these new ES cells to a mouse embryo. The results were disconcerting. Around 20% of the mice developed cancer from the cells. The researchers hypothesized that the cause was one or more of the genes that were used to create the ES cell.

By using different sets of genes in the human cell study, the researchers showed you don't need the same four genes to create an ES cell. The hope is that the researchers will find a combination of genes that do not cause cancer.

Once the scientists find a set of genes that don't cause cancer, this research should blow the stem cell field wide open. We still don't know if ES cells will work to actually cure disease. But ethical ES cells should open the spigot of federal funds so American scientists can finally research this subject to its full extent. Then we'll see if ES cells can really live up to their hype. Or if we need to pursue other ways to cure these illnesses.

Read the original here:
Human Embryonic Stem (ES) Cells from Skin Cells ...

To Read More: Human Embryonic Stem (ES) Cells from Skin Cells …
categoriaSkin Stem Cells commentoComments Off on Human Embryonic Stem (ES) Cells from Skin Cells … | dataMarch 15th, 2017
Read All

Science in Focus: Creating Neurons from Skin Cells to Understand Autism – ScienceBlog.com (blog)

By Dr. Matthew Watson


ScienceBlog.com (blog)
Science in Focus: Creating Neurons from Skin Cells to Understand Autism
ScienceBlog.com (blog)
Studying brain disorders is complicated for many reasons, not the least being the ethics of obtaining living neurons. To overcome that obstacle, UC San Francisco postdoc Aditi Deshpande, PhD, is starting with skin cells. Thanks to developments in stem ...

and more »

Original post:
Science in Focus: Creating Neurons from Skin Cells to Understand Autism - ScienceBlog.com (blog)

To Read More: Science in Focus: Creating Neurons from Skin Cells to Understand Autism – ScienceBlog.com (blog)
categoriaSkin Stem Cells commentoComments Off on Science in Focus: Creating Neurons from Skin Cells to Understand Autism – ScienceBlog.com (blog) | dataMarch 15th, 2017
Read All

RenovaCare: Stem Cell Treatment Heals Burns In Weeks Not Months – Seeking Alpha

By daniellenierenberg

RenovaCare Inc. (OTCQB:RCAR) is a New York City-based biotechnology company developing its patented CellMist and SkinGun stem cell technologies for treating burns in weeks or less as well as treating chronic and acute wounds, acne scarring, and skin defects and diseases. In December, it received a U.S. patent for its SkinGun device.

Before joining RenovaCare, CEO Thomas Bold was CEO of StemCell Systems. He has more than 15 years of experience in medical biotechnology device manufacturing and stem cell platform development.

Harlan Levy: How does your CellMist technology specifically work?

Thomas Bold: Doctors isolate a high concentration of the most desirable stem cell population from a very small donor sample of the patient's own skin and suspended in the liquid CellMist Solution. It's then gently sprayed onto wound sites using our SkinGun, which looks like Captain Kirk's particle-beam gun, the "Phaser" in the Star Trek TV series.

The isolated cells include cells that proliferate rapidly in order to achieve quick re-epithelialization. This is the stage at which a burn is technically considered "healed" and patients are often discharged. The average person would recognize this healing phase as the point at which the wound develops a thin, shiny, pink-colored protective layer.

H.L.: What are existing burn treatments, and how do they compare with the SkinGun treatment?

T.B.: Traditional skin grafting has been the treatment for burns and wounds for centuries. More recently, mesh grafting has become the latest standard of care. This process surgically removes large sheets of healthy skin from the patient. Following this painful donor procedure, the sheet is punctured in a grid-like pattern to form an expandable mesh. Surgeons pull this mesh as wide as feasible and surgically stitch this skin to the patient's wound. The procedure is extremely painful, creates an additional wound at each donor site and results in poor cosmetic outcomes, often with scarred and deformed skin.

This transplanted skin can result in restricted joint movement and is unable to grow with the patient. Consequently, mesh graft patients require months and sometimes up to a year of physical therapy and can face psychological problems from the permanent disfigurement of scarring. In addition, long-term pain management with painkillers is very often necessary.

With the RenovaCare treatment technology, by spraying the patient's stem cells, the SkinGun overcomes the need for removing large sheets of donor skin, and the resultant healing does not require prolonged physical therapy. The spray procedure is gentle, and the skin that regrows looks, feels, and functions as the original skin that it replaces. Most often the healing process takes only a week.

It's very important to note here that a sheet of meshed skin covers only up to six times its original donor area. The RenovaCare system covers up to 100 times its donor skin sample. This is why the donor skin sample can be so small compared to the injured treatment area.

H.L.: What about scars and infection potential compared with conventional treatments?

T.B.: A wound heals from the edges towards the middle. The bigger the wound, the longer this process takes. And the longer this process takes, the higher the risk of infection and scarring.

Imagine a large burn of 20, 30, 40 percent of your total body surface. With our CellMist System, the doctor sprays the patient's own stem cells with a highly regenerative capacity onto the wound and, by doing so, creates tens of thousands of little regenerative islands across the wound. These islands grow outwards, ultimately connecting to each other to create a protective epithelial skin layer that covers the wound.

Experts believe the formation of this pink-colored layer marks the moment of re-epithelization where the risk of infection is reduced and the patient's wound is effectively healed. Beyond this stage, the cosmetic healing process also happens entirely natural to produce a scar-free result where, finally, skin color, tone and pigmentation are restored.

Since the RenovaCare spray procedure uses the patient's own stem cells, there isn't the risk of tissue rejection, infection, or ongoing immuno suppression therapy.

H.L.: What results have you found for patients using the SkinGun?

T.B.: We have many examples of patients recovering from severe burns within a week or two, scar-free, and walking away with unlimited joint restrictions.

In the case of one patient with severe electrical burns to over a third of his body, we were able to spray his wounds with 23 million stem cells isolated from a tiny two-inch-by two-inch sample of his own skin. Within five days of treatment, his chest and arms were already healed. Four days later, the patient was discharged from the hospital.

It's also important to note that reconstructive surgery for burn patients is especially challenging when tackling joints in the body. To this end, the authors of a case study in the reputable journal "Burns," said, "Cell-spray grafting is also especially suitable for hands and joint areas, where prolonged times to re-epithelization may significantly impact functionality and esthetic outcome."

H.L.: What different uses does the SkinGun have beside burns?

T.B.: Currently, we are focusing on severe second-degree burns, but we see the RenovaCare technology also applicable for other indications such as cosmetic procedures targeting skin pigmentation disorders, scar treatment, and other related conditions.

Our goal is to bring to market the world's most advanced technology for skin repair using a patient's own stem cells.

H.L.: Is there a record of the SkinGun use in the States and abroad?

T.B.: Having treated 72 burn patients to date, the company's early clinical target is burns with follow-on indications, including chronic wounds and cosmetic procedures.

H.L.: How much research went into creating the SkinGun and over what time period?

T.B.: The birth of RenovaCare technology goes back to the early 2000s in Berlin, Germany. Researchers, at that time, were trying to "grow" skin by seeding stem cells inside multi-dimensional bioreactors. They soon discovered that these artificial chambers were no match for the growth of the same cells when transplanted inside a human body; thus, the birth of a concept to use a patient's own wound as a natural bioreactor.

A study published in "Advances in Plastic Surgery" highlights 19 early patients with deep dermal wound burns to the face and neck, complex three-dimensional surfaces. Researchers achieved such outstanding results using our cell spray that they refused to perform further skin grafting. Instead, surgeons adopted our founding technology as their standard of care.

Let me quote from the surgeons' study, which states

"We refuse to perform a prospective randomized study with groups in which traditional skin grafting and/or wound healing are still applied for the therapy for deep dermal burns due to the excellent results in our study. The method of CEA spray application has become our standard of care for these indications. The faster wound closure, the promotion of spontaneous wound healing by keratinocyte application, as well as the preservation of donor sites are further advantages of the method."

The same paper concluded that "using a spray technique results in excellent cosmetic outcomes compared with any other method."

H.L.: How has the technology changed since then?

T.B.: Since the time of this early approach, our technology has evolved and matured significantly. Our cell isolation no longer requires complex procedures, culturing, expansion, and processing time, and our stem cell spray device no longer requires multiple hand-assembled parts. Its independent power and flow-control unit has been condensed in size from a 2-foot cube down to a 9-volt battery placed inside the handle of a single handheld spray gun.

H.L.: What is the potential market for the technology in dollars and number of patients?

T.B.: Conservatively speaking, the market for our technology exceeds $50 billion. There are nearly a million people who suffer from burns each year in the U.S. alone. According to the American Burn Association, burn injuries continue to be one of the leading causes of accidental death and injury in the U.S, and one civilian fire death occurs every two hours and forty minutes.

H.L.: How much would you estimate the treatment cost may be for each different use?

T.B.: The SkinGun technology is currently under development and not approved for clinical use in the U.S., so it's too early to talk about what the treatment will cost. We have always been mindful of reimbursement, and nearly two years ago, we commissioned an investigation into the reimbursement pathway for our CellMist System. We know that reimbursement opportunities are available by way of current coding and practices.

We have further investigated and evaluated the "bundling" approach currently advocated for by insurers and are confident that that our technology is well placed to take advantages of any shift towards such a model.

H.L: What is the schedule to get Federal Drug Administration clearance?

T.B.: In order to achieve FDA clearance for the CellMist System and the SkinGun, we will be working to show our technology is safe and prove its efficacy within applicable clinical trial formats and according to the relevant regulatory requirements. I can't speculate as to how long the FDA clearance process will take, and, therefore, it's hard to speculate when our product will be commercialized.

H.L.: What other products are you investigating and how may they work?

T.B.: We are focusing on bringing the SkinGun and our stem cell spray technology to market at this time.

H.L.: What is your background, including age, education, prior employment?

T.B.: Before joining RenovaCare I worked as the CEO of StemCell Systems GmbH, a Berlin-based biomedical company engaged in the development and commercialization of advanced cell culture bioreactors. I have more than 15 years of professional business experience in the field of medical biotechnology device manufacturing, stem cell culture technology platform development and regenerative medicine research project management and product development. I also co-founded several start-up companies in Germany.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

The rest is here:
RenovaCare: Stem Cell Treatment Heals Burns In Weeks Not Months - Seeking Alpha

To Read More: RenovaCare: Stem Cell Treatment Heals Burns In Weeks Not Months – Seeking Alpha
categoriaSkin Stem Cells commentoComments Off on RenovaCare: Stem Cell Treatment Heals Burns In Weeks Not Months – Seeking Alpha | dataMarch 15th, 2017
Read All

From skin to brain: Stem cells without genetic modification – Phys.Org

By JoanneRUSSELL25

March 15, 2017 by Grove Potter The four images, from left to right, show Keratinocyte-derive neural crest stem cells turning into neurons as shown by typical neuronal morphology. Credit: University at Buffalo.

A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.

The practical implications could be very significant, from studying genetic diseases in a dish to generating possible regenerative cures from the patient's own cells.

"It's actually quite remarkable that it happens," says Stelios T. Andreadis, PhD, professor and chair of UB's Department of Chemical and Biological Engineering, who recently published a paper on the results in the journal Stem Cells.

The identity of the cells was further confirmed by lineage tracing experiments, where the reprogrammed cells were implanted in chicken embryos and acted just as neural crest cells do.

Stem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign genetic material. The reprogrammed neural crest cells can become smooth muscle cells, melanocytes, Schwann cells or neurons.

"In medical applications this has tremendous potential because you can always get a skin biopsy," Andreadis says. "We can grow the cells to large numbers and reprogram them, without genetic modification. So, autologous cells derived from the patient can be used to treat devastating neurogenic diseases that are currently hampered by the lack of easily accessible cell sources."

The process can also be used to model disease. Skin cells from a person with a genetic disease of the nervous system can be reprogrammed into neural crest cells. These cells will have the disease-causing mutation in their chromosomes, but the genes that cause the mutation are not expressed in the skin. The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to study the disease in a dish. This is similar to induced pluripotent stem cells, but without genetic modification or reprograming to the pluripotent state.

The discovery was a gradual process, Andreadis says, as successive experiments kept leading to something new. "It was one step at a time. It was a very challenging task that took almost five years and involved a wide range of expertise and collaborators to bring it to fruition," Andreadis says. Collaborators include Gabriella Popescu, PhD, professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB; Song Liu, PhD, vice chair of biostatistics and bioinformatics at Roswell Park Cancer Institute and a research associate professor in biostatistics UB's School of Public Health and Health Professions; and Marianne Bronner, PhD, professor of biology and biological engineering, California Institute of Technology.

Andreadis credits the persistence of his then-PhD student, Vivek K. Bajpai, for sticking with it.

"He is an excellent and persistent student," Andreadis says. "Most students would have given up." Andreadis also credits a seed grant from UB's office of the Vice President for Research and Economic Development's IMPACT program that enabled part of the work.

The work recently received a $1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinson's-like symptoms in a mouse model of hypomyelinating disease.

"This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases. We are excited about this discovery and its potential impact and are grateful to NIH for the opportunity to pursue it further," Andreadis said.

The research is described in the journal Stem Cells under the title "Reprogramming Postnatal Human Epidermal Keratinocytes Toward Functional Neural Crest Fates."

Explore further: Embryonic gene Nanog reverses aging in adult stem cells

More information: Vivek K. Bajpai et al, Reprogramming Postnatal Human Epidermal Keratinocytes Toward Functional Neural Crest Fates, STEM CELLS (2017). DOI: 10.1002/stem.2583

Journal reference: Stem Cells

Provided by: University at Buffalo

The fountain of youth may reside in an embryonic stem cell gene named Nanog.

Caltech scientists have converted cells of the lower-body region into facial tissue that makes cartilage, in new experiments using bird embryos. The researchers discovered a "gene circuit," composed of just three genes, that ...

Scientists at the University of Newcastle, UK, have used a combination of small molecules to turn cells isolated from human skin into Schwann cells - the specialised cells that support nerves and play a role in nerve repair. ...

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. The process requires ...

(Phys.org)A team of researchers affiliated with New York and Dalhousie Universities, in the U.S. and Canada respectively, has found a possible intermediate cell type that might help understand the evolutionary process ...

German researchers succeed in obtaining brain and spinal cord cells from stem cells of the peripheral nervous system.

So they can't use smartphones or WiFi, but bacteria have evolved some seriously complex strategies to communicate with one another. And the resulting interactions are a delicate balance of cooperation and, in some cases, ...

New research led by the UK's Centre for Ecology & Hydrology has revealed for the first time that flower-rich habitats are key to enhancing the survival of bumblebee families between years.

A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that ...

The evolution of land animals has been shaped by barriers such as oceans and mountains which have divided them and sent them down different genetic paths.

(Phys.org)A trio of researchers with Anglia Ruskin University in the U.K. and the Australian National University has found that the male fiddler crab uses its oversized claw to get the attention of a prospective mate and ...

A 60-year-old mystery has been solved by biochemists at The University of Western Australia investigating the origin of a type of digestion-inhibiting proteins thought only to exist in two plant families that contain the ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

The rest is here:
From skin to brain: Stem cells without genetic modification - Phys.Org

To Read More: From skin to brain: Stem cells without genetic modification – Phys.Org
categoriaSkin Stem Cells commentoComments Off on From skin to brain: Stem cells without genetic modification – Phys.Org | dataMarch 15th, 2017
Read All

Page 72«..1020..71727374..8090..»


Copyright :: 2025